Ischemic Heart Disease
📧 Sign up to get email alerts when something new happens for Ischemic Heart Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2025-09-25Clinical Trial Update: Safety and Efficacy Study of Gene Therapy for Acute Myocardial Infarction in Korea [Phase 2]
A Phase 2 safety and efficacy trial of a gene therapy for acute myocardial infarction in Korea has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2025-09-05Clinical Trial Update: Addressing Social Vulnerabilities in Cardiovascular Disease [NA]
A UCSF-sponsored clinical trial addressing social vulnerabilities in cardiovascular disease has been withdrawn. The study targeted congestiv…
-
CLINICAL_TRIALS withdrawal · 2022-09-22Clinical Trial Update: Adipose Stromal Cells Injection in the Myocardium for Induction of Revascularization [Phase 3]
Phase 3 trial of adipose stromal cell injection in the myocardium for revascularization was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2016-11-16Clinical Trial Update: Lower Leg Remote Ischemic Preconditioning in Elective Percutaneous Coronary Intervention (PCI)
A clinical trial evaluating lower-leg remote ischemic preconditioning during elective percutaneous coronary intervention has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2016-09-20Clinical Trial Update: An Efficacy and Safety Study for Nesiritide in Heart Failure Patients With Reduced Kidney Function Undergoing Coronary Artery Bypass Graft Surgery Requiring Cardiopulmonary Bypass (CPB Pump or Heart Lung Machine) [Phase 3]
A Phase 3 trial evaluating nesiritide in heart failure patients with reduced kidney function undergoing coronary artery bypass graft surgery…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2016-05-11Clinical Trial Update: Effectiveness of Statins on Lipid Goal Attainment and Lipid Parameters in PCI Patients
A clinical trial evaluating the effectiveness of statins on lipid goal attainment in patients undergoing percutaneous coronary intervention …
-
CLINICAL_TRIALS withdrawal · 2015-06-08Clinical Trial Update: GS-6615 in Adults With Chronic Stable Angina and Coronary Artery Disease [Phase 2]
A Phase 2 trial of GS-6615 for chronic stable angina and coronary artery disease has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2015-04-27Clinical Trial Update: Interleukin-4 (IL-4) as a Marker of Atherosclerosis [NA]
A clinical trial evaluating interleukin-4 as a biomarker for atherosclerosis has been withdrawn.
-
EMA withdrawal · 2009-04-23Teva Pharma B.V. withdraws its marketing authorisation application for Clopidogrel Teva Pharma (clopidogrel hydrobromide)
Teva Pharma B.V. has withdrawn its marketing authorisation application for Clopidogrel Teva Pharma (clopidogrel hydrobromide).